2017-2022 Global and Japan Antiulcer drugs Market Analysis Report

July 2017 | 124 pages | ID: 25C742C8C0DEN
JP Research

Abstracts

The global Antiulcer drugs market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Antiulcer drugs market's development status and future trend in Japan, focuses on top players in Japan, also splits Antiulcer drugs market by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players include

• Astellas Pharma Inc.
• JEAN-MARIE PHARMACAL CO. LTD
• AstraZeneca AB
• Hanmi Pharm. Co., Ltd
• Enal Drugs Pvt. Ltd.
• Takeda Pharmaceutical Company Limited
• Metrochem API Pvt. Ltd
• Nang Kuang Pharmacutical Co.,Ltd
• Bright Future Pharmaceuticals Factory
• Dr.Reddy`s Laboratories Limited
• Eisai Co.,Ltd.
• KYOWA CHEMICAL INDUSTRY CO.,LTD.
• Dead Sea Bromine Company Ltd.(Magnesia Products SBU)
• Scora S.A.
• Yonsung Fine Chemicals Co.,Ltd.
• PHARMACIA LIMITED
• Everlight Chemical Industrial Corporation.
• TOWA PHARMACEUTICAL CO., LTD.
• DAIICHI SANKYO ESPHA CO., LTD.
• Nichi-iko Pharmaceutical Co.,Ltd
• Sawai Pharmaceutical Co.,Ltd.
• OHARA Pharmaceutical Co.,Ltd.
• Teva Takeda Pharma Ltd.
• Elmed Eisai Co., Ltd.
• NIPRO CORPORATION
• KOKANOD PHARMACEUTICAL CO.,LTD.
• SANWA KAGAKU KENKYUSHO CO.,LTD.

Geographically, this report splits the Japan market into 5 regions:

• Tokyo
• Yokohama
• Osaka
• Nagoya
• Others

On the basis of product, the Antiulcer drugs market is primarily split into

Antiulcer drugs Market, by H2 receptor antagonist

• Ranitidine
• Famotidine
• Cimetidine
• Nizatidine
• Roxatidine
• Ebrotidine
• Lafutidine
• Mifentidine

Antiulcer drugs Market, by H+-K+-ATP enzyme inhibitor

• Omeprazole
• Lansoprazole
• Pantoprazole
• Rabeprazole
• Tenatoprazole
• Esomeprazole
• Ilaprazole
• Tenprazole
• Disuprazole
• Leminoprazole

Antiulcer drugs Market, by Others

• Aluminum hydroxide
• Colloidal Bismuth Pectin
• Sucralfate
• Vitamin U Belladonna and Al
• bismuth potassium citrate
• sodium bicarbonate
• calcium carbonate
• magnesium oxide
• Glycopyrrolate
• Cascara
• Pirenzepine
• Gastridine
• Magnesium trisilicate
• Misoprostol

Key Applications

• Digestive Department
• Internal medicine
• Pharmacy
• Clinic

Contents

1 ANTIULCER DRUGS OVERVIEW

1.1 Product Overview and Scope of Antiulcer drugs
1.2 Japan Antiulcer drugs Market by Applications/End Users
  1.2.1 Japan Antiulcer drugs Sales () and Market Share Comparison by Applications (2012-2022)
  1.2.2 Digestive Department
  1.2.3 Internal medicine
  1.2.4 Pharmacy
  1.2.5 Clinic
1.3 Japan Antiulcer drugs Market by Regions
  1.3.1 Japan Antiulcer drugs Market Size (Million USD) Comparison by Regions (2012-2022)
  1.3.2 Tokyo Antiulcer drugs Status and Prospect (2012-2022)
  1.3.3 Yokohama Antiulcer drugs Status and Prospect (2012-2022)
  1.3.4 Osaka Antiulcer drugs Status and Prospect (2012-2022)
  1.3.5 Nagoya Antiulcer drugs Status and Prospect (2012-2022)
  1.3.6 Others in Japan Antiulcer drugs Status and Prospect (2012-2022)
1.4 Japan Market Size (Sales and Revenue) of Antiulcer drugs (2012-2022)
  1.4.1 Japan Antiulcer drugs Sales () and Growth Rate (%)(2012-2022)
  1.4.2 Japan Antiulcer drugs Revenue (Million USD) and Growth Rate (2012-2022)
1.5 Classification of Antiulcer drugs by H2 receptor antagonist
  1.5.1 Japan Antiulcer drugs Sales () Comparison by Types (2012-2022)
  1.5.2 Japan Antiulcer drugs Sales () Market Share by Types in 2016
  1.5.3 Ranitidine
  1.5.4 Famotidine
  1.5.5 Cimetidine
  1.5.6 Nizatidine
  1.5.7 Roxatidine
1.6 Classification of Antiulcer drugs by H+-K+-ATP enzyme inhibitor
  1.6.1 Japan Antiulcer drugs Sales () Comparison by Types (2012-2022)
  1.6.2 Japan Antiulcer drugs Sales () Market Share by Types in 2016
  1.6.3 Omeprazole
  1.6.4 Lansoprazole
  1.6.5 Pantoprazole
  1.6.6 Rabeprazole
  1.6.7 Tenatoprazole
1.7 Classification of Antiulcer drugs by Others
  1.7.1 Japan Antiulcer drugs Sales () Comparison by Types (2012-2022)
  1.7.2 Japan Antiulcer drugs Sales () Market Share by Types in 2016
  1.7.3 Aluminum hydroxide
  1.7.4 Colloidal Bismuth Pectin
  1.7.5 Sucralfate
  1.7.6 Vitamin U Belladonna and Al
  1.7.7 bismuth potassium citrate

2 JAPAN ANTIULCER DRUGS MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Japan Antiulcer drugs Sales and Market Share of Key Players/Manufacturers (2012-2017)
2.2 Japan Antiulcer drugs Revenue and Share by Players/Manufacturers (2012-2017)
2.3 Japan Antiulcer drugs Average Price () by Players/Manufacturers (2012-2017)
2.4 Japan Antiulcer drugs Market Competitive Situation and Trends
  2.4.1 Japan Antiulcer drugs Market Concentration Rate
  2.4.2 Japan Antiulcer drugs Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in Japan Market
2.5 Japan Players/Manufacturers Antiulcer drugs Manufacturing Base Distribution, Sales Area, Product Types

3 JAPAN ANTIULCER DRUGS SALES AND REVENUE BY REGIONS (2012-2017)

3.1 Japan Antiulcer drugs Sales () and Market Share by Regions (2012-2017)
3.2 Japan Antiulcer drugs Revenue (Million USD) and Market Share by Regions (2012-2017)
3.3 Japan Antiulcer drugs Price () by Regions (2012-2017)

4 JAPAN ANTIULCER DRUGS SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2012-2017)

4.1 Japan Antiulcer drugs Sales () and Market Share by Type (2012-2017)
4.2 Japan Antiulcer drugs Revenue (Million USD) and Market Share by Type (2012-2017)
4.3 Japan Antiulcer drugs Price () by Type (2012-2017)
4.4 Japan Antiulcer drugs Sales Growth Rate (%) by Type (2012-2017)

5 JAPAN ANTIULCER DRUGS SALES BY APPLICATION (2012-2017)

5.1 Japan Antiulcer drugs Sales () and Market Share by Applications (2012-2017)
5.2 Japan Antiulcer drugs Sales Growth Rate (%) by Applications (2012-2017)
5.3 Market Drivers and Opportunities

6 JAPAN ANTIULCER DRUGS PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

6.1 Astellas Pharma Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Antiulcer drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Astellas Pharma Inc. Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.1.4 Main Business/Business Overview
6.2 JEAN-MARIE PHARMACAL CO. LTD
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Antiulcer drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 JEAN-MARIE PHARMACAL CO. LTD Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.2.4 Main Business/Business Overview
6.3 AstraZeneca AB
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Antiulcer drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 AstraZeneca AB Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hanmi Pharm. Co., Ltd
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Antiulcer drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hanmi Pharm. Co., Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Enal Drugs Pvt. Ltd.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Antiulcer drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Enal Drugs Pvt. Ltd. Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Takeda Pharmaceutical Company Limited
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Antiulcer drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Takeda Pharmaceutical Company Limited Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Metrochem API Pvt. Ltd
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Antiulcer drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Metrochem API Pvt. Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Nang Kuang Pharmacutical Co.,Ltd
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Antiulcer drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Nang Kuang Pharmacutical Co.,Ltd Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bright Future Pharmaceuticals Factory
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Antiulcer drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bright Future Pharmaceuticals Factory Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Dr.Reddy`s Laboratories Limited
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Antiulcer drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Dr.Reddy`s Laboratories Limited Antiulcer drugs Sales (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Eisai Co.,Ltd.
6.12 KYOWA CHEMICAL INDUSTRY CO.,LTD.
6.13 Dead Sea Bromine Company Ltd.(Magnesia Products SBU)
6.14 Scora S.A.
6.15 Yonsung Fine Chemicals Co.,Ltd.
6.16 PHARMACIA LIMITED
6.17 Everlight Chemical Industrial Corporation.
6.18 TOWA PHARMACEUTICAL CO., LTD.
6.19 DAIICHI SANKYO ESPHA CO., LTD.
6.20 Nichi-iko Pharmaceutical Co.,Ltd
6.21 Sawai Pharmaceutical Co.,Ltd.
6.22 OHARA Pharmaceutical Co.,Ltd.
6.23 Teva Takeda Pharma Ltd.
6.24 Elmed Eisai Co., Ltd.
6.25 NIPRO CORPORATION
6.26 KOKANOD PHARMACEUTICAL CO.,LTD.
6.27 SANWA KAGAKU KENKYUSHO CO.,LTD.

7 ANTIULCER DRUGS MANUFACTURING COST ANALYSIS

7.1 Antiulcer drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antiulcer drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Antiulcer drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antiulcer drugs Major Players/Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 JAPAN ANTIULCER DRUGS MARKET SIZE (SALES AND REVENUE) FORECAST (2017-2022)

11.1 Japan Antiulcer drugs Sales (), Revenue (Million USD) Forecast (2017-2022)
11.2 Japan Antiulcer drugs Sales () Forecast by Type (2017-2022)
11.3 Japan Antiulcer drugs Sales () Forecast by Application (2017-2022)
11.4 Japan Antiulcer drugs Sales () Forecast by Regions (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List